 Home Merck SeronoContact UsGlossaryReferencesSearchSite Guide |
|
Concern
TreatmentPregnancyExperiencesTreatment
 |
The Doctor's Visit |
|
Personalised Treatment |
 |
Female Treatments |
 |
First Step |
 |
Second Step |
 |
Follicle-stimulating Hormone |
 |
Human Menopausal Gonadotropin |
|
Human Chorionic Gonadotropin |
|
Gonadotropin-releasing Hormone |
|
Luteinising Hormone |
|
Third Step |
|
Male Treatments |
|
Implications of Treatment |
|
Enhance Your Well-being |
|
Questions to Ask Your Doctor |
|
Treatment FAQ |
|
Devices for Administration of Medication |
Human Menopausal Gonadotropin (hMG)
Human Menopausal Gonadotropin (hMG) is essentially a mixture of FSH, LH and hCG (the latter being a hormone that has Luteinising Hormone-like activity.
hMG hormone treatments are extracted and purified from the urine of postmenopausal women. Regardless of the level of purification claimed by this urinary product, it is not a truly purified gonadotropin. Urinary protein contaminants prevent truly precise control of fertility hormones in women.
hMG products are used to treat infertility in women caused by anovulation by stimulating follicular development, as well as to treat infertility in men with hypo- or normagonadotropic hypogonadism, and in combination with hCG to stimulate spermatogenesis.
© 2003-2008 Merck Serono S.A. Please read our Legal Statement. US residents should consult the Serono, Inc. fertility website at www.fertilitylifelines.com Last Updated: 5/6/2008 |  |